75
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution

, , , ORCID Icon, & ORCID Icon
Pages 3941-3950 | Published online: 25 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Saneya Pandrowala, Robin L Jones, Sanjay Gupta & Ashish Gulia. (2021) Desmoid Fibromatosis: is the Current Picture Changing?. Future Oncology 17:25, pages 3397-3408.
Read now

Articles from other publishers (5)

Dechao Yuan, Yong Liu, Xiang Fang, Fan Wu, Senlin Lei, Linqi Tu, Fuguo Kuang, Yawei Gou, Chunfu Gong, Wenli Zhang & Hong Duan. (2024) Surgery combined with anlotinib for local control of patients with resectable extremity desmoid fibromatosis: a retrospective study. Frontiers in Pharmacology 15.
Crossref
S. Tsukamoto, T. Takahama, A. F. Mavrogenis, Y. Tanaka, Y. Tanaka & C. Errani. (2022) Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review. MUSCULOSKELETAL SURGERY 107:1, pages 7-18.
Crossref
Hassan Alsayegh, Tariq Alzaid, Abdulrahman Khawaji, Meshaal Alshaalan & Maram Alothman. (2022) Aggressive gluteal fibromatosis: a rare case associated with spontaneous superior gluteal artery pseudoaneurysm. Skeletal Radiology.
Crossref
Gaya Spolverato, Giulia Capelli, Bernd Kasper & Mrinal Gounder. (2022) Management of Desmoid Tumors. Surgical Oncology Clinics of North America 31:3, pages 447-458.
Crossref
Jianzheng Wang, Hongle Li, Hui Wang, Qingli Li, Xuanye Bai, Huifang Lv, Caiyun Nie, Beibei Chen, Weifeng Xu, Shuiping Tu & Xiaobing Chen. (2022) Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review. Frontiers in Oncology 11.
Crossref